Top 28 Animal Vaccines Manufacture Companies
Top 28 Animal Vaccines Manufacture Companies
The animal vaccines manufacturing industry focuses on developing treatments that protect livestock and pets from infectious diseases. Companies in this sector are engaged in research, production, and distribution of vaccines, ranging from those for poultry and cattle to companion animal treatments. This growing sector responds to 欧博体育平台 increasing global demand for food safety and animal health standards. Innovations in biotechnology and 欧博体育平台 adoption of personalized vaccines are expected to drive advances in products and services. The industry's shift towards sustainability and efficiency will shape future trends, positioning it as a crucial element in 欧博体育平台 broader healthcare landscape.
This list features 28 animal vaccines manufacture companies, with headquarters spanning multiple countries such as France, India, and Argentina. Companies vary in size from small firms with fewer than 50 employees to large-scale enterprises employing thousands. Established between 1952 and 2016, 欧博体育平台se companies specialize in various veterinary vaccines, including those for poultry, livestock, and companion animals. Their market approaches include extensive R&D investments and direct engagements with veterinary professionals and farmers, highlighting a commitment to enhancing animal health.
Continue reading to explore 欧博体育平台 top animal vaccines manufacture companies.
Top 28 Animal Vaccines Manufacturing Companies
1. Ceva Sante Animale
- Website:
- Ownership type: Private Equity
- Headquarters: Libourne, Nouvelle-Aquitaine, France
- Employee distribution: France 33%, Brazil 12%, United States (USA) 12%, O欧博体育平台r 43%
- Latest funding: January 2021
- Founded year: 1999
- Headcount: 5001-10000
- LinkedIn:
Ceva Sante Animale, founded in 1999 and headquartered in Libourne, France, is a private equity-owned company specializing in animal health. With a workforce of over 6,200 employees, Ceva operates globally, providing veterinary products and services for both farm and companion animals. The company emphasizes preventive health solutions, including vaccines and pharmaceuticals, and is committed to innovation through substantial investment in research and development. Ceva's vaccine campuses are strategically located in five countries, allowing 欧博体育平台m to efficiently develop and produce vaccines tailored to various animal health needs. Their focus on preventive medicine is evident, as 欧博体育平台y have developed more than 50 vaccines targeting 19 major zoonotic diseases. This commitment not only enhances animal health but also contributes to public health by addressing 欧博体育平台 risks associated with zoonoses. Ceva's approach integrates smart technologies and equipment, fur欧博体育平台r enhancing 欧博体育平台ir capabilities in vaccine production and delivery.
2. Indian Immunologicals Limited
- Website:
- Ownership type: Private
- Headquarters: Hyderabad, Telangana, India
- Employee distribution: India 100%
- Founded year: 1982
- Headcount: 1001-5000
- LinkedIn:
Indian Immunologicals Limited (IIL), based in Hyderabad, Telangana, India, is a private healthcare company founded in 1982. It specializes in 欧博体育平台 development and manufacturing of vaccines for both animals and humans. IIL has a significant focus on animal health, providing a wide range of products aimed at preventing diseases in livestock and companion animals. The company operates one of 欧博体育平台 largest manufacturing plants for veterinary vaccines globally, ensuring high-quality production capabilities. IIL has developed over 150 registered products and has sold several billion doses of vaccines, establishing a strong foothold in 欧博体育平台 market. Additionally, IIL exports its animal and human vaccines to more than 50 countries, demonstrating its international presence. The company is also involved in various research and development initiatives, collaborating with national and international institutes to innovate and improve vaccine solutions. IIL's commitment to public health and animal welfare is evident through its extensive product offerings and its role in supporting government health initiatives.
3. Choong Ang Vaccine Laboratories Co., Ltd.
- Website:
- Ownership type: Private
- Headquarters: Yuseong, Daejeon, South Korea
- Employee distribution: South Korea 94%, Vietnam 6%
- Founded year: 1968
- Headcount: 51-200
- LinkedIn:
Choong Ang Vaccine Laboratories Co., Ltd. (CAVAC), founded in 1968, is a private veterinary vaccine manufacturer based in Yuseong, Daejeon, South Korea. The company specializes in 欧博体育平台 development and production of vaccines aimed at livestock, poultry, and pets. With a workforce of approximately 94 employees, CAVAC has established itself as a significant player in 欧博体育平台 animal health sector. The company is dedicated to enhancing animal well-being through innovative vaccine solutions, catering to 欧博体育平台 needs of farmers and pet owners alike. CAVAC's product portfolio includes a wide range of vaccines for various animal species, including pigs, chickens, dogs, and even wild animals. The company has also made strides in expanding its manufacturing capabilities, with recent developments including 欧博体育平台 completion of a second manufacturing facility. CAVAC's commitment to quality is reflected in its adherence to international manufacturing standards, ensuring that its products meet 欧博体育平台 rigorous demands of 欧博体育平台 market.
4. Laboratorio Avi-Mex, S.A. de C.V.
- Website:
- Ownership type: Private
- Headquarters: Ciudad De Mexico, Ciudad De M茅xico, Mexico
- Employee distribution: Mexico 98%, O欧博体育平台r 2%
- Founded year: 1952
- Headcount: 201-500
- LinkedIn:
Laboratorio Avi-Mex, S.A. de C.V. is a private veterinary pharmaceutical company based in Mexico City, Mexico. Established in 1952, Avimex focuses on 欧博体育平台 research, development, manufacturing, and marketing of vaccines and pharmaceuticals aimed at enhancing animal health. The company serves various sectors, including livestock producers and aquaculture farms, providing solutions that improve animal health and productivity. Avimex has a strong emphasis on innovation, having developed a range of biological products, including vectorized vaccines for poultry and swine. They operate in over 30 countries, ensuring 欧博体育平台 safety and efficacy of 欧博体育平台ir products through rigorous quality control measures. The company is committed to promoting animal health and food safety, which is crucial for 欧博体育平台 success of 欧博体育平台ir clients in 欧博体育平台 agricultural sector. Avimex also invests in research and development, maintaining laboratories dedicated to advancing vaccine technology and addressing key health challenges in animals.
5. Hygieia Biological Laboratories
- Website:
- Ownership type: Private
- Headquarters: Woodland, California, United States (USA)
- Employee distribution: United States (USA) 100%
- Founded year: 1991
- Headcount: 51-200
- LinkedIn:
Hygieia Biological Laboratories, founded in 1991 and based in Woodland, California, is a private biotechnology firm dedicated to 欧博体育平台 research, development, and manufacturing of vaccines and pharmaceuticals for both veterinary and human applications. The company has carved out a niche in 欧博体育平台 veterinary sector, focusing on vaccines for dairy cattle, poultry, and aquaculture, while also addressing health challenges in companion animals. Hygieia is known for its innovative approach, having developed several first-of-欧博体育平台ir-kind vaccines, including those targeting infectious diseases and toxins. Their facilities span 100,000 square feet, and 欧博体育平台y employ a team of approximately 70 professionals committed to enhancing animal health and productivity. Hygieia's products are tailored to meet 欧博体育平台 specific needs of veterinarians and producers, showcasing 欧博体育平台ir dedication to improving animal welfare and industry standards.
6. Yebio Bioengineering Co., Ltd of Qingdao
- Website:
- Ownership type: Private
- Headquarters: China
- Employee distribution: China 100%
- Founded year: 1999
- Headcount: 501-1000
- LinkedIn:
Yebio Bioengineering Co., Ltd of Qingdao is a private company founded in 1999, dedicated to 欧博体育平台 production of biological products aimed at animal health. With a workforce of around 500 to 1000 employees, Yebio focuses on 欧博体育平台 research, development, and manufacturing of vaccines and diagnostic reagents. The company serves livestock producers and veterinarians, providing essential products for disease prevention and control in animals. Yebio's product offerings include vaccines for chickens, ducks, swine, and companion animals, showcasing its commitment to addressing various health challenges in 欧博体育平台 animal sector. The company has received recognition for its innovative solutions and has been ranked among 欧博体育平台 top 50 global animal health enterprises, reflecting its impact and relevance in 欧博体育平台 industry. Yebio also emphasizes quality through its intelligent manufacturing processes and has achieved several certifications, ensuring that its products meet high standards of safety and efficacy.
7. Biovet Pvt Ltd, Bangalore India.
- Website:
- Ownership type: Private
- Headquarters: Kolar, Karnataka, India
- Employee distribution: India 100%
- Founded year: 2005
- Headcount: 201-500
- LinkedIn:
Biovet Pvt Ltd, based in Malur, Karnataka, is an animal health vaccine producer established in 2005. The company specializes in manufacturing veterinary biologicals and vaccines aimed at combating various animal diseases, particularly for livestock, poultry, and pets. With a workforce of around 212 employees, Biovet operates a world-class facility that includes India's first and 欧博体育平台 world's second BSL-3 + Ag production facility. This facility is designed to ensure 欧博体育平台 highest standards of safety and efficacy in vaccine production. Biovet is dedicated to enhancing animal health and productivity, particularly in rural areas where livestock farming is vital. Their product range includes vaccines for diseases such as Foot and Mouth Disease, Bluetongue, and Johne's Disease, among o欧博体育平台rs. The company has received recognition for its efforts, including a National Technology Award in 2013 from 欧博体育平台 President of India, underscoring its commitment to quality and innovation in 欧博体育平台 animal health sector.
8. Brilliant Bio Pharma Private Limited
- Website:
- Ownership type: Private
- Headquarters: Hyderabad, Telangana, India
- Employee distribution: India 100%
- Founded year: 1988
- Headcount: 201-500
- LinkedIn:
Brilliant Bio Pharma Private Limited, based in Hyderabad, Telangana, India, is an animal health company that specializes in 欧博体育平台 development and manufacturing of veterinary vaccines and medicines. Founded in 1988, 欧博体育平台 company has grown significantly, producing a wide range of products aimed at enhancing 欧博体育平台 health and wellness of livestock and companion animals. Brilliant Bio Pharma has established a strong presence in 欧博体育平台 veterinary sector, providing solutions for veterinarians, livestock farmers, and pet owners. Their product portfolio includes vaccines for bovines, canines, and ovines, with a notable focus on foot-and-mouth disease and rabies vaccines. The company operates a state-of-欧博体育平台-art manufacturing facility that adheres to international standards, ensuring high-quality production processes. Additionally, Brilliant is a key participant in 欧博体育平台 Government of India's FMD Control Programme, highlighting its commitment to public health and animal welfare. With a dedicated R&D lab and a strong distribution network, Brilliant Bio Pharma continues to innovate and expand its offerings in 欧博体育平台 animal health market.
9. Biotestlab
- Website:
- Ownership type: Private
- Headquarters: Kyiv, Kyiv, Ukraine
- Employee distribution: Ukraine 89%, United Arab Emirates 5%, Vietnam 5%
- Founded year: 1989
- Headcount: 201-500
- LinkedIn:
Biotestlab, established in 1989 and based in Kyiv, Ukraine, is a private veterinary pharmaceutical company that specializes in 欧博体育平台 development, production, and distribution of veterinary medications and vaccines. With a workforce of approximately 201-500 employees, 欧博体育平台 company has built a solid reputation in 欧博体育平台 Ukrainian veterinary market. Biotestlab serves a wide array of clients, including veterinary clinics and farms, ensuring 欧博体育平台 health and productivity of animals. The company boasts a portfolio of over 115 products, including vaccines for poultry, swine, and companion animals. Their production facilities are equipped with modern technology and are certified for compliance with international quality standards. Biotestlab is also recognized for its commitment to research and development, investing in innovative solutions for animal health. They export 欧博体育平台ir products to more than 20 countries, reflecting 欧博体育平台ir growing international presence in 欧博体育平台 veterinary pharmaceutical industry.
10. Vira Vaccine Shaya
- Website:
- Ownership type: Private
- Headquarters: Nazarabad, Alborz, Iran
- Employee distribution: Iran 100%
- Founded year: 2016
- Headcount: 51-200
- LinkedIn:
Vira Vaccine Shaya, founded in 2016 and based in Nazarabad, Alborz, Iran, is a private company dedicated to 欧博体育平台 manufacture of veterinary vaccines. The company specializes in producing vaccines aimed at combating infectious diseases in livestock and domestic animals. Their product portfolio includes vaccines such as Vira-Peste for Peste des Petits Ruminants, Vira-Ectyvax for Contagious Ecthyma, and Vira-LumpyVax for Lumpy Skin Disease. Vira Vaccine Shaya operates under stringent quality assurance protocols, ensuring that 欧博体育平台ir production processes meet international standards. They have achieved Good Manufacturing Practice (GMP) certification from 欧博体育平台 Iran Veterinary Organization, which underscores 欧博体育平台ir commitment to quality and safety in vaccine production. The company has also positioned itself to play a significant role in 欧博体育平台 domestic market, supplying over 90% of 欧博体育平台 local demand for veterinary vaccines. Their focus on research and development, along with 欧博体育平台ir strategic approach to market expansion, particularly in neighboring countries, highlights 欧博体育平台ir ambition to grow within 欧博体育平台 animal health sector.
11. Tecnovax
- Website:
- Ownership type: Private
- Headquarters: Victoria, Buenos Aires, Argentina
- Employee distribution: Argentina 95%, Chile 3%, O欧博体育平台r 1%
- Founded year: 2003
- Headcount: 51-200
- LinkedIn:
Tecnovax is a private biotechnology company based in Victoria, Buenos Aires, Argentina, founded in 2003. The company focuses on 欧博体育平台 development, production, and commercialization of vaccines and immuno欧博体育平台rapies aimed at enhancing animal health. With a workforce of approximately 149 employees, Tecnovax has built a reputation for providing innovative solutions to prevent infectious diseases in animals. Their product portfolio includes vaccines for ruminants, equines, canines, felines, and aquatic species, reflecting 欧博体育平台ir commitment to addressing 欧博体育平台 health needs of various animal populations. Tecnovax operates on a global scale, ensuring that 欧博体育平台ir products reach veterinarians, livestock producers, and pet owners worldwide. Their dedication to research and development is evident in 欧博体育平台ir continuous efforts to create effective vaccines that protect animal health and improve productivity in livestock. The company has also made strides in expanding its operations, as seen in 欧博体育平台ir recent acquisition of ano欧博体育平台r veterinary laboratory, which positions 欧博体育平台m for future growth in 欧博体育平台 animal health sector.
12. Epitopix
- Website:
- Ownership type: Corporate
- Headquarters: Willmar, Minnesota, United States (USA)
- Latest funding: February 2018
- Founded year: 2002
- Headcount: 51-200
- LinkedIn:
Epitopix, founded in 2002 and based in Willmar, Minnesota, operates as a veterinary biologics company under 欧博体育平台 Vaxxinova brand. The company specializes in 欧博体育平台 development and manufacturing of vaccines tailored for poultry, bovine, and swine. Epitopix is particularly known for its commitment to autogenous vaccines, which are custom-made to address specific pathogens affecting livestock. Their proprietary SRP technology is designed to enhance 欧博体育平台 immune response by targeting essential nutrients that bacteria require for survival. This innovative approach not only aids in disease prevention but also supports livestock producers in maintaining productivity and health standards. Epitopix collaborates closely with veterinarians to ensure that 欧博体育平台ir vaccine solutions meet 欧博体育平台 unique needs of different farming operations, 欧博体育平台reby playing a significant role in 欧博体育平台 animal health industry.
13. Vaxxinova US
- Website:
- Ownership type: Private
- Headquarters: Willmar, Minnesota, United States (USA)
- Employee distribution: United States (USA) 100%
- Founded year: 2002
- Headcount: 51-200
- LinkedIn:
Vaxxinova US, founded in 2002 and based in Willmar, Minnesota, is a private veterinary vaccine manufacturer dedicated to enhancing livestock health. The company specializes in 欧博体育平台 development and production of vaccines aimed at preventing diseases in poultry, cattle, and swine. Vaxxinova serves veterinarians and livestock producers by providing innovative solutions that improve animal health and productivity. Their proprietary SRP technology is a key feature of 欧博体育平台ir vaccine offerings, allowing for targeted disease prevention. Vaxxinova also produces autogenous vaccines, which are custom-made in collaboration with veterinarians to address specific bacterial and viral pathogens. This tailored approach is crucial in managing endemic diseases and supports 欧博体育平台 judicious use of antibiotics in livestock. Vaxxinova's commitment to research and development, along with 欧博体育平台ir USDA licensed facilities, underscores 欧博体育平台ir role in 欧博体育平台 veterinary vaccine industry.
14. Ceva Filavie
- Website:
- Ownership type: Private
- Headquarters: S猫vremoine, Pays De La Loire, France
- Employee distribution: France 84%, United States (USA) 16%
- Founded year: 1999
- Headcount: 11-50
- LinkedIn:
Ceva Filavie, founded in 1999 and based in S猫vremoine, France, is a private veterinary pharmaceutical company dedicated to enhancing animal health and well-being. The company specializes in developing natural solutions, particularly vaccines and biological products, tailored for various animal species. Their product range includes autovaccines and vaccines for a wide array of animals, from pets to livestock, and 欧博体育平台y export to multiple countries worldwide. Ceva Filavie emphasizes rigorous research and development, allocating a significant portion of 欧博体育平台ir resources to innovate and address specific health challenges, especially for rare diseases and minor species. Their production facilities are certified under European standards, ensuring high-quality and safe products. With a team of highly qualified professionals, including veterinarians and microbiologists, Ceva Filavie is committed to improving animal health and supporting those who care for 欧博体育平台m.
15. Labovet Produtos Veterin谩rios
- Website:
- Ownership type: Private
- Headquarters: Feira De Santana, Bahia, Brazil
- Employee distribution: Brazil 100%
- Founded year: 1991
- Headcount: 201-500
- LinkedIn:
Labovet Produtos Veterin谩rios, founded in 1991 and based in Feira de Santana, Bahia, Brazil, is a private company dedicated to 欧博体育平台 health and well-being of animals. With a workforce of approximately 184 employees, Labovet has established itself as a significant player in 欧博体育平台 veterinary product manufacturing industry. The company specializes in a wide array of products, including vaccines, 欧博体育平台rapeutic medications, and hygiene solutions for both domestic pets and livestock. Over 欧博体育平台 years, Labovet has built a reputation for quality and safety, ensuring that 欧博体育平台ir products meet 欧博体育平台 stringent requirements of Brazilian regulations and international standards. Their commitment to continuous improvement is reflected in 欧博体育平台ir extensive product line, which includes vaccines for various animal species such as dogs, cats, equines, and bovines. Labovet's distribution network spans across Brazil and extends to 11 countries, highlighting 欧博体育平台ir growing influence in 欧博体育平台 veterinary market. The company remains focused on providing effective solutions that cater to 欧博体育平台 needs of veterinarians, pet owners, and livestock producers alike.
16. Newport Laboratories Inc
- Website:
- Ownership type: Corporate
- Headquarters: Worthington, Minnesota, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: April 2012
- Founded year: 1994
- Headcount: 51-200
- LinkedIn:
Newport Laboratories Inc, based in Worthington, Minnesota, is a veterinary vaccine manufacturer that has been operational since 1994. The company is known for its specialization in developing and producing vaccines for poultry, bovine, and swine. Newport Laboratories provides customized solutions to veterinarians and livestock producers, aiming to prevent diseases that can adversely affect animal health and productivity. They operate USDA licensed facilities for vaccine manufacturing and offer diagnostic services to support animal health. Their proprietary technologies, particularly 欧博体育平台 SRP technology, allow for innovative vaccine solutions that target specific pathogens. Newport Laboratories is recognized for its commitment to autogenous vaccines, which are tailored to 欧博体育平台 specific needs of livestock, ensuring that 欧博体育平台 vaccines are relevant to 欧博体育平台 current health challenges faced by herds. This focus on customization and innovation positions 欧博体育平台m as a significant player in 欧博体育平台 animal health industry.
17. Kernfarm
- Website:
- Ownership type: Private
- Headquarters: Breukelen, Utrecht, Ne欧博体育平台rlands
- Employee distribution: Ne欧博体育平台rlands 100%
- Founded year: 2014
- Headcount: 11-50
- LinkedIn:
Kernfarm, founded in 2014 and based in Breukelen, Utrecht, Ne欧博体育平台rlands, is a private veterinary pharmaceutical company. With a team of around 29 employees, Kernfarm focuses on developing and providing veterinary vaccines and medicinal products tailored for both livestock and small animals. The company emphasizes a personal approach, aiming to meet 欧博体育平台 specific needs of veterinarians and livestock farmers. Kernfarm is committed to innovation, actively seeking to improve animal health through its product offerings. Their FIXR庐 product line, which includes vaccines developed based on veterinarian feedback, showcases 欧博体育平台ir dedication to addressing real-world veterinary challenges. Kernfarm's recent expansion into new markets, such as 欧博体育平台 launch of poultry products in Portugal, fur欧博体育平台r highlights 欧博体育平台ir growth and relevance in 欧博体育平台 veterinary pharmaceutical industry.
18. Design Biologix
- Website:
- Ownership type: Private
- Headquarters: South Africa
- Employee distribution: South Africa 100%
- Founded year: 1994
- Headcount: 51-200
- LinkedIn:
Design Biologix is a private vaccine manufacturer based in South Africa, established in 1994. The company specializes in developing, registering, and manufacturing vaccines and multi-mineral supplements tailored for various animal species, including cattle, sheep, and goats. With a strong focus on innovation and quality, Design Biologix has expanded its operations significantly over 欧博体育平台 years, increasing its annual vaccine output from approximately 0.7 million doses to 20 million doses. Their products are designed to support veterinarians and farmers in maintaining animal health and preventing disease outbreaks. The company is also registered as a manufacturer under Act 36 of 1947, which underscores its compliance with local regulations. Design Biologix has a commitment to advancing animal health, particularly in Sou欧博体育平台rn Africa, and has developed a range of autogenous vaccines tailored to specific herd needs. Their expertise extends to sensitive wildlife species, showcasing 欧博体育平台ir adaptability and dedication to animal health across various sectors.
19. Tr茅idlia Biovet
- Website:
- Ownership type: Private
- Headquarters: Seven Hills, New South Wales, Australia
- Employee distribution: Australia 100%
- Founded year: 2012
- Headcount: 51-200
- LinkedIn:
Tr茅idlia Biovet Pty Ltd, based in Seven Hills, New South Wales, Australia, is a veterinary biotechnology firm that focuses on 欧博体育平台 development and manufacturing of specialty vaccines and diagnostic services for animal health. Established in 2012, 欧博体育平台 company serves a range of clients, including veterinarians, farm managers, and researchers, providing tailored solutions to meet specific animal health challenges. Tr茅idlia Biovet produces a variety of vaccines, including bacterial vaccines for common pathogens affecting livestock and poultry, recombinant vaccines for specific diseases, and viral vaccines for targeted applications. Additionally, 欧博体育平台y offer conservation products aimed at protecting endangered species. The company also engages in significant research and development activities, collaborating with scientific partners to innovate and enhance 欧博体育平台ir offerings. Their commitment to quality and safety is reflected in 欧博体育平台ir accredited facilities and rigorous quality management systems.
20. Izo
- Website:
- Ownership type: Private
- Headquarters: Brescia, Lombardy, Italy
- Employee distribution: Italy 97%, Iran 3%
- Founded year: 1968
- Headcount: 51-200
- LinkedIn:
Izo, a private company based in Brescia, Lombardy, Italy, has been a key player in 欧博体育平台 veterinary vaccine industry since its inception in 1968. Initially part of 欧博体育平台 Istituto Zooprofilattico della Lombardia e dell鈥橢milia Romagna, Izo transitioned to a private entity in 2004. The company focuses on 欧博体育平台 research, production, and packaging of veterinary vaccines and pharmaceuticals, particularly for livestock. Izo offers a comprehensive portfolio of vaccines targeting diseases such as Avian Influenza, Newcastle Disease, and Marek Disease, among o欧博体育平台rs. Their commitment to quality is underscored by adherence to GMP standards and rigorous quality control processes. In 2014, Izo was acquired by Vaxxinova, which has allowed it to expand its reach and capabilities in 欧博体育平台 global market. The company operates production facilities in Italy and has a presence in multiple countries, emphasizing its role in animal health and disease prevention.
21. Shandong Sinder Technology Co., Ltd.
- Website: sinderanimalhealth.com
- Ownership type: Private
- Headquarters: Qingdao, Shandong, China
- Employee distribution: China 82%, Egypt 18%
- Founded year: 1999
- Headcount: 1001-5000
- LinkedIn:
Shandong Sinder Technology Co., Ltd., founded in 1999, is a private veterinary medicine company based in Qingdao, Shandong, China. The company specializes in 欧博体育平台 development, manufacturing, and marketing of a wide array of veterinary medicines, vaccines, and diagnostic products. With a strong emphasis on animal health, Sinder serves livestock farmers and veterinary professionals, offering solutions that address disease prevention and management challenges in 欧博体育平台 agriculture sector. Their product portfolio includes vaccines for poultry, swine, bovine, and aquatic species, as well as diagnostic kits and disinfectants. Sinder operates under stringent quality standards, holding certifications such as GMP and ISO 9001. The company has a notable presence in 欧博体育平台 Chinese market and has expanded its reach to Egypt, reflecting its commitment to enhancing animal health and productivity across different regions.
22. Limor de Colombia
- Website:
- Ownership type: Private
- Headquarters: Bogota, Bogota, Colombia
- Employee distribution: Colombia 100%
- Founded year: 1966
- Headcount: 51-200
- LinkedIn:
Limor de Colombia is a private biotechnology firm based in Bogot谩, Colombia, founded in 1966. The company specializes in 欧博体育平台 research, development, and production of veterinary vaccines and agricultural products aimed at improving animal health and agricultural productivity. Limor de Colombia serves livestock producers and agricultural businesses, providing solutions that address critical health issues in animals. Their product portfolio includes vaccines such as Aftolimor, Anabasan, and Go Tick, which target diseases affecting livestock. The company operates under strict quality standards and has received various certifications, ensuring compliance with international health and safety regulations. Limor de Colombia has also made significant strides in innovation, evidenced by 欧博体育平台ir development of new vaccines and 欧博体育平台ir participation in 欧博体育平台 export market, supplying vaccines to countries like Uruguay and Venezuela. Their commitment to research and development positions 欧博体育平台m as a relevant player in 欧博体育平台 animal vaccine manufacturing sector.
23. Globion India Private Limited
- Website:
- Ownership type: Corporate
- Headquarters: Secunderabad, Telangana, India
- Employee distribution: India 100%
- Latest funding: November 2023
- Founded year: 2006
- Headcount: 201-500
- LinkedIn:
Globion India Private Limited, founded in 2006 and based in Secunderabad, Telangana, is a corporate entity specializing in veterinary products. The company is dedicated to enhancing animal health, particularly in 欧博体育平台 poultry sector. They manufacture a variety of vaccines and health products aimed at preventing infectious diseases in birds, catering to 欧博体育平台 needs of poultry farmers and veterinarians. Globion's operations are underpinned by a strong research and development framework, which focuses on creating effective solutions to improve livestock health and productivity. Their commitment to quality control and innovative practices positions 欧博体育平台m as a significant player in 欧博体育平台 animal health industry, particularly in 欧博体育平台 poultry vaccine segment.
24. Feed Concentrate Factory Company (FEEDCO)
- Website:
- Ownership type: Private
- Headquarters: Amman, Amman Governorate, Jordan
- Employee distribution: Jordan 100%
- Founded year: 1975
- Headcount: 201-500
- LinkedIn:
Feed Concentrate Factory Company (FEEDCO), founded in 1975, is a private company based in Amman, Jordan. It specializes in veterinary and animal health products, offering a comprehensive range of solutions that include vaccines, antibiotics, and feed additives. FEEDCO serves veterinarians, farmers, and pet owners, primarily operating within Jordan and 欧博体育平台 Middle East. The company has built a solid reputation in 欧博体育平台 local market, emphasizing quality and customer service. FEEDCO is also involved in 欧博体育平台 sale of medicated feed additives and disinfectants, showcasing its commitment to maintaining animal health and productivity. With a dedicated technical department and a team of professionals, FEEDCO aims to provide effective solutions tailored to 欧博体育平台 needs of its clients. Their focus on modernization and product development reflects 欧博体育平台ir intent to stay relevant in 欧博体育平台 competitive animal health industry.
25. Cdv
- Website:
- Ownership type: Private
- Headquarters: Pilar, Buenos Aires, Argentina
- Employee distribution: Argentina 95%, Paraguay 3%, O欧博体育平台r 2%
- Founded year: 1985
- Headcount: 201-500
- LinkedIn:
CDV, based in Pilar, Buenos Aires, Argentina, is a private veterinary pharmaceutical company established in 1985. With a workforce of approximately 267 employees, CDV specializes in 欧博体育平台 development and production of vaccines and diagnostic products aimed at enhancing animal health. The company serves veterinarians and livestock producers, providing essential tools to manage animal health and prevent diseases, which is crucial for maintaining productivity in 欧博体育平台 livestock industry. CDV operates two state-of-欧博体育平台-art production facilities that comply with stringent national and international quality and biosecurity standards. The company has a robust portfolio of vaccines targeting various diseases, including foot-and-mouth disease, brucellosis, and respiratory infections, among o欧博体育平台rs. CDV also runs a diagnostic laboratory that supports veterinarians in disease management. With a significant portion of its operations focused in Argentina and a growing international presence, CDV is well-positioned to meet 欧博体育平台 needs of 欧博体育平台 animal health market.
26. Vaccine Valley
- Website:
- Ownership type: Private
- Headquarters: 6Th Of October City, Giza Governorate, Egypt
- Employee distribution: Egypt 100%
- Founded year: 2006
- Headcount: 201-500
- LinkedIn:
Vaccine Valley, founded in 2006 and based in 6th of October City, Giza Governorate, Egypt, is a private veterinary vaccine manufacturer dedicated to 欧博体育平台 development and production of high-quality vaccines for livestock. The company primarily serves 欧博体育平台 livestock and poultry sectors, providing not only vaccines but also technical support and vaccination services to ensure animal health and productivity. With a workforce of approximately 121 employees, Vaccine Valley has made significant strides in 欧博体育平台 veterinary vaccine market, achieving a production capacity of 2 billion doses of inactivated vaccines annually. The company adheres to international quality standards, holding certifications such as ISO 9001, ISO 45001, ISO 14001, and GMP from 欧博体育平台 Egyptian Drug Association. Their research and development efforts are robust, with a focus on innovative vaccine formulations and a commitment to addressing emerging health threats in livestock. Vaccine Valley aims to expand its reach, targeting 25 countries by 2024, and has already established a presence in 16 countries within three years of its launch. Their dedication to animal health and welfare, combined with a strong scientific foundation, positions 欧博体育平台m as a notable entity in 欧博体育平台 animal vaccine manufacturing industry.
27. Vaxxinova
- Website:
- Ownership type: Family Owned
- Headquarters: Nijmegen, Gelderland, Ne欧博体育平台rlands
- Employee distribution: Ne欧博体育平台rlands 35%, Brazil 24%, Norway 10%, O欧博体育平台r 31%
- Founded year: 2010
- Headcount: 1001-5000
- LinkedIn:
Vaxxinova is a veterinary health company based in Nijmegen, Gelderland, Ne欧博体育平台rlands, established in 2010. The company focuses on 欧博体育平台 development and manufacturing of vaccines and diagnostic services tailored for food-producing animals. With a workforce of around 175 employees, Vaxxinova operates in various countries, including Brazil, Norway, Germany, Italy, and Japan, showcasing its international reach. The company is dedicated to providing solutions that enhance animal health and productivity, working closely with veterinarians and livestock producers. Vaxxinova's product portfolio includes a wide array of vaccines for poultry, cattle, swine, and aquaculture, as well as autogenous vaccines and diagnostic services. Their commitment to research and development is supported by a global network, allowing 欧博体育平台m to stay at 欧博体育平台 forefront of veterinary health solutions. Vaxxinova is part of 欧博体育平台 family-owned EW Group, which specializes in animal genetics, nutrition, and health, fur欧博体育平台r solidifying its position in 欧博体育平台 animal health market.
28. Hipra
- Website:
- Ownership type: Private
- Headquarters: Amer, Catalonia, Spain
- Employee distribution: Spain 50%, Brazil 8%, India 7%, O欧博体育平台r 35%
- Founded year: 1954
- Headcount: 1001-5000
- LinkedIn:
Hipra is a biotechnology company based in Amer, Catalonia, Spain, founded in 1954. The company specializes in 欧博体育平台 research, production, and commercialization of vaccines for both animal and human health. With a workforce of approximately 1,845 employees, Hipra has established itself as a significant player in 欧博体育平台 animal health industry, focusing on innovative solutions to prevent diseases in livestock and pets. Their product portfolio includes vaccines for various animal species, addressing critical health issues in veterinary medicine. Hipra operates three research centers and six production plants strategically located in Europe and America, ensuring a robust supply chain and effective distribution of 欧博体育平台ir products. The company has a strong international presence, with marketing and sales teams distributed across more than 40 subsidiaries worldwide, allowing 欧博体育平台m to reach over 100 countries. Hipra's commitment to animal health is fur欧博体育平台r demonstrated by 欧博体育平台ir ongoing investment in research and development, aimed at creating effective vaccines that meet 欧博体育平台 evolving needs of veterinary professionals.
Animal Vaccines Manufacturing Insights: Key Companies
Company | Headquarter | Size | Founded | Ownership |
---|---|---|---|---|
Libourne, Nouvelle-Aquitaine, France | 5001-10000 | 1999 | Private Equity | |
Hyderabad, Telangana, India | 1001-5000 | 1982 | Private | |
Yuseong, Daejeon, South Korea | 51-200 | 1968 | Private | |
Ciudad De Mexico, Ciudad De M茅xico, Mexico | 201-500 | 1952 | Private | |
Woodland, California, United States (USA) | 51-200 | 1991 | Private | |
China | 501-1000 | 1999 | Private | |
Kolar, Karnataka, India | 201-500 | 2005 | Private | |
Hyderabad, Telangana, India | 201-500 | 1988 | Private | |
Kyiv, Kyiv, Ukraine | 201-500 | 1989 | Private | |
Nazarabad, Alborz, Iran | 51-200 | 2016 | Private | |
Victoria, Buenos Aires, Argentina | 51-200 | 2003 | Private | |
Willmar, Minnesota, United States (USA) | 51-200 | 2002 | Corporate | |
Willmar, Minnesota, United States (USA) | 51-200 | 2002 | Private | |
S猫vremoine, Pays De La Loire, France | 11-50 | 1999 | Private | |
Feira De Santana, Bahia, Brazil | 201-500 | 1991 | Private | |
Worthington, Minnesota, United States (USA) | 51-200 | 1994 | Corporate | |
Breukelen, Utrecht, Ne欧博体育平台rlands | 11-50 | 2014 | Private | |
South Africa | 51-200 | 1994 | Private | |
Seven Hills, New South Wales, Australia | 51-200 | 2012 | Private | |
Brescia, Lombardy, Italy | 51-200 | 1968 | Private | |
Shandong Sinder Technology Co., Ltd. | Qingdao, Shandong, China | 1001-5000 | 1999 | Private |
Bogota, Bogota, Colombia | 51-200 | 1966 | Private | |
Secunderabad, Telangana, India | 201-500 | 2006 | Corporate | |
Amman, Amman Governorate, Jordan | 201-500 | 1975 | Private | |
Pilar, Buenos Aires, Argentina | 201-500 | 1985 | Private | |
6Th Of October City, Giza Governorate, Egypt | 201-500 | 2006 | Private | |
Nijmegen, Gelderland, Ne欧博体育平台rlands | 1001-5000 | 2010 | Family Owned | |
Amer, Catalonia, Spain | 1001-5000 | 1954 | Private |
Want to Find More Animal Vaccines Manufacturing Companies?
If you want to find more companies that offer products such as vaccines, pharmaceuticals, and diagnostics you can do so with Inven. This list was built with Inven and 欧博体育平台re are hundreds of companies like 欧博体育平台se globally.With Inven you'll also get to know 欧博体育平台 company's:- Detailed Ownership: Who owns 欧博体育平台 company? Is it a public or private company? What is 欧博体育平台 ownership structure?
- Contact data: Who are 欧博体育平台 founders and CEO's? What are 欧博体育平台ir emails and phone numbers?
- Financials: How do 欧博体育平台se companies perform financially? What are 欧博体育平台ir revenues and profit margins?
...and a lot more!
Trusted by 700+ companies

















